[144] Snowflake Inc. SEC Filing

Rhea-AI Filing Summary

MiMedx Group, Inc. (MDXG) – Form 4 insider filing: Chief Financial Officer Doug Rice reported a Rule 16b-3 Code F transaction on 07/03/2025 related to the vesting of restricted stock units. A total of 12,749 common shares were withheld and disposed at a price of $6.34 per share to satisfy tax-withholding obligations. Following the transaction, Rice’s direct ownership stands at 188,024 shares.

The disposition was not an open-market sale; Code F denotes tax-payment with shares, a routine administrative event. There were no derivative security transactions disclosed and no indication of a 10b5-1 trading plan. The filing does not signal a strategic change in position but updates Rice’s beneficial ownership after the equity award’s vesting.

Positive

• None.

Negative

• CFO’s share count decreased by 12,749 shares (≈6% of his prior direct holdings) due to tax-withholding, marginally reducing insider ownership.

Insights

Securities Analyst

TL;DR: Routine tax-withholding reduces CFO’s stake by ~6%, minimal market impact.

The Form 4 shows a standard administrative disposition. Rice relinquished 12,749 shares (≈$0.08 million) to cover taxes on vested RSUs, leaving 188,024 shares. Code F confirms no discretionary selling. The transaction amounts to roughly 6% of his pre-transaction holdings, immaterial to MiMedx’s float. Investors should not read this as a bearish signal; it is common after equity awards vest. No derivatives, 10b5-1 plan, or pattern of selling is indicated, so overall impact is neutral.

Corporate Governance Expert

TL;DR: Filing reflects compliance with Section 16; no governance red flags.

The timely Form 4 demonstrates management’s adherence to disclosure rules. Code F filings are expected when RSUs vest. The CFO still retains a substantive equity stake (≈$1.2 million at $6.34), maintaining alignment with shareholder interests. No joint filings or large-scale disposals appear, and the single-line reporting format suggests straightforward ownership. Accordingly, the event is governance-neutral and not considered materially impactful to shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	323713	72249365.07	337000000	07/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	07/07/2025	Options Granted 05/29/2019	Issuer			323713	07/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	06/10/2025	1859	390315.64
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	06/17/2025	7294	1517152.00
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	06/26/2025	424852	93189806.24
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	06/27/2025	306502	68185276.36
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	06/30/2025	217432	48656538.41
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	07/01/2025	294125	63910926.55
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	07/02/2025	187815	40671970.88
Frank Slootman Suite 3A 106 East Babcock Street Bozeman MT 59715	Class A	07/03/2025	178949	39577203.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did MiMedx CFO Doug Rice report in the latest Form 4?

He disclosed the withholding and disposal of 12,749 common shares on 07/03/2025 to cover taxes on vested RSUs.

At what price were the MiMedx shares disposed?

The shares were valued at $6.34 per share, as stated in the filing.

How many MiMedx shares does the CFO now own?

After the transaction, Doug Rice directly owns 188,024 shares of MDXG common stock.

What does Transaction Code F mean in a Form 4?

Code F indicates shares were withheld to pay taxes on equity award vesting, not an open-market sale.

Was a Rule 10b5-1 plan involved in this transaction?

No; the filing does not reference a 10b5-1 plan, implying a routine administrative action.

Does the filing suggest the CFO is selling MDXG shares voluntarily?

No; the shares were automatically withheld for tax purposes, so it does not signal discretionary selling.